Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 112

Similar articles for PubMed (Select 23220981)

1.

The different mechanisms of periprocedural myocardial infarction and their impact on in-hospital outcome.

Muschart X, Slimani A, Jamart J, Chenu P, Dangoisse V, Gabriel L, Guédès A, Marchandise B, Schröder E.

J Invasive Cardiol. 2012 Dec;24(12):655-60.

2.

Periprocedural myocardial injury in chronic total occlusion percutaneous interventions: a systematic cardiac biomarker evaluation study.

Lo N, Michael TT, Moin D, Patel VG, Alomar M, Papayannis A, Cipher D, Abdullah SM, Banerjee S, Brilakis ES.

JACC Cardiovasc Interv. 2014 Jan;7(1):47-54. doi: 10.1016/j.jcin.2013.07.011. Epub 2013 Dec 11.

3.

Association of baseline C-reactive protein levels with periprocedural myocardial injury in patients undergoing percutaneous bifurcation intervention: a CACTUS study subanalysis.

Niccoli G, Sgueglia GA, Latib A, Crea F, Colombo A; CACTUS Study Group.

Catheter Cardiovasc Interv. 2014 Jan 1;83(1):E37-44. doi: 10.1002/ccd.25102. Epub 2013 Aug 5.

PMID:
23813627
4.

Prognostic implications of creatine kinase-MB elevation after percutaneous coronary intervention: results from the Evaluation of Drug-Eluting Stents and Ischemic Events (EVENT) registry.

Lindsey JB, Kennedy KF, Stolker JM, Gilchrist IC, Mukherjee D, Marso SP, Pencina MJ, Kleiman NS, Cohen DJ.

Circ Cardiovasc Interv. 2011 Oct 1;4(5):474-80. doi: 10.1161/CIRCINTERVENTIONS.111.962233. Epub 2011 Oct 4.

5.

Comparison of the prognosis of spontaneous and percutaneous coronary intervention-related myocardial infarction.

Leonardi S, Thomas L, Neely ML, Tricoci P, Lopes RD, White HD, Armstrong PW, Giugliano RP, Antman EM, Califf RM, Newby LK, Mahaffey KW.

J Am Coll Cardiol. 2012 Dec 4;60(22):2296-304. doi: 10.1016/j.jacc.2012.09.005. Epub 2012 Nov 1.

6.

Impact of periprocedural creatine kinase-MB isoenzyme release on long-term mortality in contemporary percutaneous coronary intervention.

Andron M, Stables RH, Egred M, Alahmar AE, Shaw MA, Roberts E, Albouaini K, Grayson AD, Perry RA, Palmer ND.

J Invasive Cardiol. 2008 Mar;20(3):108-12.

7.

Impact of long-term statin therapy on postprocedural myocardial infarction in patients undergoing nonemergency percutaneous coronary intervention.

Gordin J, Haider A, Swaminathan RV, Kim LK, Minutello RM, Bergman G, Wong SC, Feldman DN.

Am J Cardiol. 2012 Nov 15;110(10):1397-404. doi: 10.1016/j.amjcard.2012.06.052. Epub 2012 Aug 2.

PMID:
22858186
8.

Different cardiac biomarkers to detect peri-procedural myocardial infarction in contemporary coronary stent trials: impact on outcome reporting.

Vranckx P, Farooq V, Garg S, Van Es GA, Silber S, Windecker S, Stone GW, Serruys PW.

Heart. 2012 Oct;98(19):1424-30. doi: 10.1136/heartjnl-2012-302267. Epub 2012 Jul 21.

PMID:
22821273
9.

Plaque prolapse after stent implantation in patients with acute myocardial infarction: an intravascular ultrasound analysis.

Hong YJ, Jeong MH, Ahn Y, Sim DS, Chung JW, Cho JS, Yoon NS, Yoon HJ, Moon JY, Kim KH, Park HW, Kim JH, Cho JG, Park JC, Kang JC.

JACC Cardiovasc Imaging. 2008 Jul;1(4):489-97. doi: 10.1016/j.jcmg.2008.04.004.

10.

Does creatine kinase-MB (CK-MB) isoenzyme elevation following percutaneous coronary intervention with drug-eluting stents impact late clinical outcome?

Javaid A, Buch AN, Steinberg DH, Pinto Slottow T, Roy P, Pichard AD, Satler LF, Kent KM, Gevorkian N, Xue Z, Suddath WO, Waksman R.

Catheter Cardiovasc Interv. 2007 Nov 15;70(6):826-31.

PMID:
17621656
11.

Effect on periprocedural myocardial infarction of intra-coronary nicorandil prior to percutaneous coronary intervention in stable and unstable angina.

Hwang J, Lee HC, Kim BW, Yang MJ, Park JS, Park JH, Lee HW, Oh J, Choi JH, Cha KS, Hong TJ, Song S, Kim SP.

J Cardiol. 2013 Aug;62(2):77-81. doi: 10.1016/j.jjcc.2013.03.017. Epub 2013 Jun 2.

12.

Frequency and clinical consequences associated with sidebranch occlusion during stent implantation using zotarolimus-eluting and paclitaxel-eluting coronary stents.

Popma JJ, Mauri L, O'Shaughnessy C, Overlie P, McLaurin B, Almonacid A, Kirtane A, Leon MB.

Circ Cardiovasc Interv. 2009 Apr;2(2):133-9. doi: 10.1161/CIRCINTERVENTIONS.108.832048. Epub 2009 Apr 1.

13.

Lack of efficacy of clopidogrel pre-treatment in the prevention of myocardial damage after elective stent implantation.

van der Heijden DJ, Westendorp IC, Riezebos RK, Kiemeneij F, Slagboom T, van der Wieken LR, Laarman GJ.

J Am Coll Cardiol. 2004 Jul 7;44(1):20-4.

14.

Incidence of periprocedural myocardial infarction and cardiac biomarker testing after percutaneous coronary intervention in Japan: results from a multicenter registry.

Arai T, Yuasa S, Miyata H, Kawamura A, Maekawa Y, Ishikawa S, Noma S, Inoue S, Sato Y, Kohsaka S, Fukuda K.

Heart Vessels. 2013 Nov;28(6):714-9. doi: 10.1007/s00380-012-0314-x. Epub 2012 Dec 29. Erratum in: Heart Vessels. 2013 Nov;28(6):720.

PMID:
23274577
15.

Multicenter international registry of unprotected left main coronary artery percutaneous coronary intervention with drug-eluting stents in patients with myocardial infarction.

Lee MS, Sillano D, Latib A, Chieffo A, Zoccai GB, Bhatia R, Sheiban I, Colombo A, Tobis J.

Catheter Cardiovasc Interv. 2009 Jan 1;73(1):15-21. doi: 10.1002/ccd.21712.

PMID:
19089930
16.

With the "universal definition," measurement of creatine kinase-myocardial band rather than troponin allows more accurate diagnosis of periprocedural necrosis and infarction after coronary intervention.

Lim CC, van Gaal WJ, Testa L, Cuculi F, Arnold JR, Karamitsos T, Francis JM, Petersen SE, Digby JE, Westaby S, Antoniades C, Kharbanda RK, Burrell LM, Neubauer S, Banning AP.

J Am Coll Cardiol. 2011 Feb 8;57(6):653-61. doi: 10.1016/j.jacc.2010.07.058.

17.

The prognosis of periprocedural myocardial infarction after percutaneous coronary interventions.

Zimarino M, Affinito V.

Cardiovasc Revasc Med. 2013 Jan-Feb;14(1):32-6. doi: 10.1016/j.carrev.2012.10.006. Epub 2012 Nov 17. Review.

PMID:
23164601
18.

Is periprocedural CK-MB a better indicator of prognosis after emergency and elective percutaneous coronary intervention compared with post-procedural cardiac troponins?

Gollop ND, Dhullipala A, Nagrath N, Myint PK.

Interact Cardiovasc Thorac Surg. 2013 Nov;17(5):867-71. doi: 10.1093/icvts/ivt303. Epub 2013 Jul 9. Review.

19.

Frequency, causes, predictors, and clinical significance of peri-procedural myocardial infarction following percutaneous coronary intervention.

Park DW, Kim YH, Yun SC, Ahn JM, Lee JY, Kim WJ, Kang SJ, Lee SW, Lee CW, Park SW, Park SJ.

Eur Heart J. 2013 Jun;34(22):1662-9. doi: 10.1093/eurheartj/eht048. Epub 2013 Feb 12. Review.

20.

Prognostic value of creatine kinase-myocardial band isoenzyme elevation following percutaneous coronary intervention: a meta-analysis.

Jang JS, Jin HY, Seo JS, Yang TH, Kim DK, Kim DS, Cho KI, Kim BH, Je HG, Park YH.

Catheter Cardiovasc Interv. 2013 May;81(6):959-67. doi: 10.1002/ccd.24542. Epub 2012 Nov 14. Review.

PMID:
22744792
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk